Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01220401 · ClinicalTrials.gov registry record · NA
Efficacy of a Brief Nightmare Treatment for Veterans
A NA study of PTSD and Suicide, sponsored by University of Tul.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
- 1
- Study location
NCT01220401: Completed NA study of PTSD and Suicide, sponsored by University of Tul.
NCT01220401 is a NA study of PTSD and Suicide that has completed, run by University of Tul. The registered enrollment target is 21 participants, below the 302-participant average among 154 other PTSD trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01220401, a NA study of PTSD and Suicide, has completed, sponsored by University of Tul.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to find out what effects Exposure, Rescripting, and Relaxation Therapy (ERRT) has on nightmares and associated problems in veterans.
Primary Outcome
This fill-in-the-blank variable assesses the number of nights the individual experienced nightmares in the past week (range = 0 - 7 nights). Higher values indicate more nights with nightmares (worse outcome).
Conditions Studied
Interventions
- BEHAVIORAL exposure, relaxation, and rescription therapy
Study Locations (1)
Oklahoma
- The University of Tulsa - Tulsa
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2010-10 |
| Est. Completion | 2011-08 |
| Phase | NA |
What the finished NCT01220401 record still lists
NCT01220401 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 302-participant average among 154 other PTSD trials with a reported enrollment target (93% lower).
The record links to 3 conditions, with PTSD appearing as the primary indexed condition, and to 1 intervention - of which exposure, relaxation, and rescription therapy is the first listed.
NCT01220401 reports a single indexed study location in Oklahoma.
Frequently Asked Questions
What is clinical trial NCT01220401 about?
NCT01220401 is a clinical study titled "Efficacy of a Brief Nightmare Treatment for Veterans". The purpose of this study is to find out what effects Exposure, Rescripting, and Relaxation Therapy (ERRT) has on nightmares and associated problems in veterans.
What is the current status of trial NCT01220401?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2010-10. Estimated completion is 2011-08.
What conditions does trial NCT01220401 study?
This clinical trial studies the following conditions: PTSD, Suicide, Sleep Disorders.
What interventions are being tested in trial NCT01220401?
The interventions under investigation include: exposure, relaxation, and rescription therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT01220401?
This trial is sponsored by University of Tul, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01220401 being conducted?
This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for PTSD
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01220401's enrollment target sits among peer trials
21 139th of 154 higher than 16 of 154 other PTSD trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other PTSD trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Treatments for Insomnia in Veterans With PTSD
RECRUITING · NA
-
REstoring Mental Health Through COmmUnity-based Psychological Services in New York City
RECRUITING · NA
-
Recovery Through Inhibitory Learning, Self-Efficacy Building, Problem Solving, and Community Building
RECRUITING · NA
-
Project Safe Guard-Trauma
RECRUITING · NA
-
Neuromodulation of the Fear Extinction Circuit Using Temporally and Anatomically Specific TMS in Humans
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia